rofecoxib has been researched along with Hyperaldosteronism in 1 studies
Hyperaldosteronism: A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gitelman's syndrome is manifested by hypokalemic alkalosis, hypomagnesemia, hypocalciuria, normotensive hyperreninemia and hyperaldosteronism." | 1.31 | Successful treatment by cyclooxyenase-2 inhibitor of refractory hypokalemia in a patient with Gitelman's syndrome. ( Farfel, Z; Gurevitz, O; Mayan, H, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mayan, H | 1 |
| Gurevitz, O | 1 |
| Farfel, Z | 1 |
1 other study available for rofecoxib and Hyperaldosteronism
| Article | Year |
|---|---|
Successful treatment by cyclooxyenase-2 inhibitor of refractory hypokalemia in a patient with Gitelman's syndrome.
Topics: Adult; Alkalosis; Calcium; Cyclooxygenase Inhibitors; Humans; Hyperaldosteronism; Hypokalemia; Lacto | 2002 |